Short answer
Oric Pharmaceuticals, Inc. (ORIC) filed an 8-K current report with the SEC on February 23, 2026 reporting Item 8.01 (Other Events). New $200M ATM offering launched Feb 26, 2026 via Jefferies; replaces prior $200M 2024 program now closed.
Oric Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- New $200M ATM offering launched Feb 26, 2026 via Jefferies; replaces prior $200M 2024 program now closed
- Prior ATM sold 13.48M shares for ~$139.7M gross proceeds, implying ~$10.37/share avg sale price
- Fresh $200M capacity signals continued equity dilution risk for existing shareholders
- ATM structure allows ORIC to drip-sell shares at market prices with no fixed timeline or floor price
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Oric Pharmaceuticals, Inc. 8-K filings
Get the next ORIC 8-K as it lands
Follow ORIC for push alerts, or ask the research agent what this filing means.